This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The following is a guest article by Frank Forte, CEO at EnableComp The healthcar...
For GLP-1 receptor agonists specifically, adherence challenges are a major conce...
Medsender, the AI-powered workflow automation platform for healthcare providers,...
Eli Lilly is continuing to invest big in US pharma manufacturing, with the addit...
It can be very overwhelming scrolling though job board after job board in search...
Merck said its “once-in-a-lifetime” drug Keytruda could be subject to price redu...
One of biotech's best-funded startups has just raised a huge new round to take i...
Ginkgo Bioworks’ stock $DNA fell by around 13% premarket Wednesday after the com...
The Federal Trade Commission is continuing its investigation into anticompetitiv...
For the first time since 2018, dermatology-focused Leo Pharma forecasts it could...
Medicare Part D spending on 10 diabetes drugs increased 364% between 2019 and 20...
The contract negotiation process between providers and payers is now more comple...
To Candel Therapeutics CEO Paul Peter Tak, the biotech’s viral immunotherapy has...
Drug compounders have sued the FDA to put the weight loss and diabetes drug sema...
Emalex Biosciences said its daily oral tablet helped reduce relapses for childre...
What You Should Know: – Atropos Health, a pioneer in in translating clinical da...